Savara SVRA
NASDAQ SVRA
$5.08 +0.01 (+0.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Savara (SVRA) Share-based Compensation (2010 - 2026)

Updated

Savara's Share-based Compensation was $7.77 million in Q2 2026, up 190.9% from $2.67 million a year earlier but down 27.6% from the prior quarter.

Analysis

Savara (SVRA) Share-based Compensation (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Savara's Share-based Compensation was $27.27 million through Jun 30, 2026, up 146.9% year-over-year; for FY2025, it came in at $14.42 million, up 46.3% from FY2024.

  • Share-based Compensation has now increased for three consecutive years, with a five-year compound annual growth rate of 23.1% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $9.86 million in FY2024 (+136.0%), $4.18 million in FY2023 (+104.7%), $2.04 million in FY2022 (-37.4%) and $3.26 million in FY2021 (-36.2%).
  • Quarterly Share-based Compensation has moved between $450,000 (Q3 2022) and $10.73 million (Q1 2026) over five years.
  • Compared with a year earlier, Share-based Compensation has increased for 14 straight quarters, with growth averaging 110.9% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was Q1 2026 (growth of 260.9%); the worst was Q3 2021 (a decline of 64.3%).
  • Per Business Quant data, SVRA's Share-based Compensation in the three quarters before Q2 2026 was $10.73 million (Q1 2026), $5.36 million (Q4 2025) and $3.43 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Savara 1.04 Bn 1.04 Bn - 7.77 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.77 Mn
Mar 31, 2026 10.73 Mn
Dec 31, 2025 5.36 Mn
Sep 30, 2025 3.43 Mn
Jun 30, 2025 2.67 Mn
Mar 31, 2025 2.97 Mn
Dec 31, 2024 3.04 Mn
Sep 30, 2024 2.37 Mn
Jun 30, 2024 2.20 Mn
Mar 31, 2024 2.26 Mn
Dec 31, 2023 1.36 Mn
Sep 30, 2023 995,000.00
Jun 30, 2023 958,000.00
Mar 31, 2023 864,000.00
Dec 31, 2022 561,000.00
Sep 30, 2022 450,000.00
Jun 30, 2022 456,000.00
Mar 31, 2022 574,000.00
Dec 31, 2021 853,000.00
Sep 30, 2021 690,000.00
API Access

Savara Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=SVRA&period=max&api_key=YOUR_API_KEY